Orthofix

OverviewSuggest Edit

Headquartered in Lewisville, TX, the company has four strategic business units that include BioStim, Biologics, Extremity Fixation and Spine Fixation. Our products are distributed in more than 70 countries around the world via Orthofix sales representatives, distributors and subsidiaries.

Founded in Verona, Italy in 1980, Orthofix has approximately 900 employees around the world who are dedicated to the development, manufacturing and distribution of orthopedic and spine products and regenerative tissue forms. Many of our innovative product offerings were cultivated through affiliations with surgeons and premiere health care organizations. Orthofix is proud to collaborate on research and development activities with leading clinical organizations such as the Musculoskeletal Transplant Foundation (MTF) and the Texas Scottish Rite Hospital for Children.

TypePublic
Founded1980
HQZ.a.i., ITMap
Websiteorthofix.com
Employee Ratings2.7More
Overall CultureA+More
View Jobs

Recent NewsAll News

Latest Updates

Employees (est.) (Dec 2019)1,055(+11%)
Revenue (FY, 2019)$460 M(+2%)
Share Price (Jan 2021)$43.6 (+2%)
Cybersecurity ratingDMore

Key People/Management at Orthofix

Ronald Matricaria

Ronald Matricaria

Director, Chairman of the Board
Maria Sainz

Maria Sainz

Director, Chair of the Compliance Committee
James Hinrichs

James Hinrichs

Director, Chair of the Audit & Finance Committee
Jason Hannon

Jason Hannon

Director
Kimberley Elting

Kimberley Elting

Chief Legal and Development Officer
Jon Serbousek

Jon Serbousek

Director, President, and Chief Executive Officer
Show more

Orthofix Office Locations

Orthofix has offices in Z.a.i., Sona, Lewisville, Sunnyvale and in 7 other locations
Z.a.i., IT (HQ)
9 Via delle Nazioni
Sona, IT
7 Via della Filanda
Willemstad, CW
A. de Veerstraat
Arcueil, FR
28 Villa Baudran
Paris, FR
259 Rue Saint-Honoré
Laichingen, DE
Gottlieb-Daimler-Straße 6
Show all (11)

Orthofix Financials and Metrics

Orthofix Revenue

Embed Graph
View revenue for all periods
Orthofix's revenue was reported to be $459.96 m in FY, 2019
USD

Revenue (Q3, 2020)

111.0m

Gross profit (Q3, 2020)

84.7m

Gross profit margin (Q3, 2020), %

76.4%

Net income (Q3, 2020)

4.7m

EBIT (Q3, 2020)

4.2m

Market capitalization (8-Jan-2021)

843.1m

Closing stock price (8-Jan-2021)

43.6

Cash (30-Sept-2020)

79.8m

EV

785.8m
Orthofix's current market capitalization is $843.1 m.
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

579.0m447.6m400.5m402.3m396.5m409.8m433.8m453.0m460.0m

Cost of goods sold

139.2m98.3m102.3m98.9m86.5m87.9m93.0m96.6m100.6m

Gross profit

439.8m349.3m298.2m303.4m310.0m321.9m340.8m356.4m359.3m

Gross profit Margin, %

76%78%74%75%78%79%79%79%78%
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Revenue

143.6m144.7m143.1m119.5m114.8m103.4m98.3m92.7m101.3m101.0m101.0m89.8m101.0m101.2m98.7m104.1m98.5m102.7m108.9m105.2m108.7m111.5m111.7m109.1m115.9m113.5m104.8m73.1m111.0m

Cost of goods sold

34.7m36.0m32.9m23.7m22.4m25.6m20.2m23.9m22.6m25.4m25.3m19.3m21.9m23.9m22.1m22.5m19.9m22.6m23.2m23.7m24.1m22.8m24.0m23.7m25.8m24.9m23.4m23.2m26.2m

Gross profit

108.9m108.7m110.3m95.8m92.4m77.8m78.0m68.8m78.7m75.6m75.7m70.4m79.0m77.3m76.5m81.6m78.6m80.2m85.8m81.5m84.6m88.7m87.7m85.4m90.0m88.6m81.4m50.0m84.7m

Gross profit Margin, %

76%75%77%80%81%75%79%74%78%75%75%78%78%76%78%78%80%78%79%77%78%80%78%78%78%78%78%68%76%
show all
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

33.2m31.1m30.5m36.8m63.7m39.6m81.2m69.6m69.7m

Accounts Receivable

146.5m107.3m75.6m61.4m59.8m2.8m63.4m77.7m86.8m

Prepaid Expenses

28.1m34.1m25.9m26.6m31.2m25.9m17.9m20.9m

Inventories

91.2m83.4m90.6m59.8m57.6m63.3m81.3m76.8m82.4m
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Cash

27.5m29.0m47.1m50.1m53.6m33.7m27.4m22.2m26.7m28.9m29.8m29.8m55.9m63.7m39.8m40.5m46.8m41.7m44.3m53.9m77.1m45.7m53.8m46.7m52.1m56.8m57.7m172.9m79.8m

Accounts Receivable

139.2m142.2m156.5m149.5m156.0m96.5m90.8m75.3m76.9m63.3m62.5m58.5m58.4m56.2m55.3m56.4m52.9m59.4m61.2m61.2m77.2m74.4m74.4m79.6m80.6m79.7m77.8m67.4m73.1m

Prepaid Expenses

20.8m21.7m21.9m25.4m28.1m34.4m29.0m27.3m28.8m43.9m39.3m25.8m24.7m31.9m19.1m19.7m20.5m19.5m17.2m18.2m31.2m35.6m34.5m16.4m21.0m19.6m21.2m20.7m18.5m

Inventories

98.0m94.7m90.9m78.4m80.8m84.7m94.9m100.2m92.8m70.9m64.3m56.7m59.2m57.8m59.8m61.3m65.0m66.3m75.9m80.1m77.7m81.7m79.9m79.1m79.1m81.0m82.7m82.0m82.9m
show all
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Net Income

(1.1m)42.8m(25.5m)(8.5m)(2.8m)3.1m6.2m13.8m(28.5m)

Depreciation and Amortization

22.8m20.6m22.7m22.9m20.9m20.8m20.1m18.7m24.7m

Inventories

(13.8m)(2.5m)(6.6m)8.1m3.1m(5.3m)(15.6m)9.7m(5.7m)

Accounts Payable

576.0k4.6m(2.3m)(6.5m)3.0m(1.8m)2.3m(170.0k)2.1m
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Net Income

(25.8m)(13.5m)12.0m23.2m30.8m4.5m2.2m(17.6m)(782.0k)(3.2m)(2.7m)(2.7m)1.2m4.7m5.2m6.2m4.9m897.0k350.0k(40.1m)25.7m7.2m11.9m

Depreciation and Amortization

11.3m17.3m5.7m11.0m15.5m5.0m10.2m15.5m6.0m11.5m17.1m5.1m10.4m15.4m4.4m8.9m13.7m5.7m11.9m18.2m6.3m13.3m22.3m

Inventories

(12.4m)(14.5m)732.0k2.2m(959.0k)(2.1m)(12.9m)(11.6m)(1.7m)2.2m5.5m(2.7m)(11.1m)(14.7m)1.7m5.3m6.9m(2.5m)(2.4m)(5.0m)(848.0k)468.0k246.0k

Accounts Payable

(2.3m)(2.2m)(3.1m)(4.4m)2.1m(7.2m)(3.5m)(8.0m)(6.7m)(5.0m)(6.8m)1.0m(950.0k)(2.2m)(4.5m)(3.8m)(2.8m)1.9m1.6m447.0k28.0k(4.8m)(3.1m)
show all
USDQ2, 2011

Financial Leverage

2.2 x
Show all financial metrics

Orthofix Cybersecurity Score

Cybersecurity ratingPremium dataset

D

65/100

Learn more about our premium products
SecurityScorecard logo

Orthofix Online and Social Media Presence

Orthofix's Trends

Embed Graph

Orthofix Company Culture

  • Overall Culture

    A+

    91/100

  • CEO Rating

    A+

    90/100

  • Compensation

    A+

    100/100

Learn more on Comparably

Orthofix News and Updates

August 24, 2020

Translational Regenerative Medicines Market is growing at a CAGR of 13.9% by 2026 | Athersys, Orthofix International N.V, Anika Therapeutics

The latest 184+ page survey report on Translational Regenerative Medicines - Global Market is released by HTF MI covering various players of the industry selected from global geographies like North America, Europe, Asia Pacific, South America & Middle East & Africa. A perfect mix of quantita…
August 01, 2018

Andrew Dubowski Joins Ortho Consulting Group

BASINGSTOKE, England, August 1, 2018 /PRNewswire/ -- Ortho Consulting Group is delighted to announce that Andrew Dubowski has joined our team as Head of International Business Development. Andrew joins the team bringing a wealth of Orthopaedic knowledge with over 20 years in the health...
July 18, 2018

Electromagnetic Therapy Device Market 2018 Global Analysis By Key Players – Orthofix Holdings, BEMER, Dolphin MPS, Curatronic, Swiss Bionic Solutions, ORIN

WiseGuyReports.Com Publish a New Market Research Report On –“ Electromagnetic Therapy Device Market 2018 Global Analysis By Key Players – Orthofix Holdings, BEMER, Dolphin MPS, Curatronic, Swiss Bionic Solutions, ORIN”. Posted via Industry Today. Follow us on Twitter @IndustryToday
April 30, 2018

Orthofix International's (OFIX) CEO Brad Mason on Q1 2018 Results - Earnings Call Transcript

January 23, 2018

Spinal Fusion Market with Current Trends Analysis 2021

Spinal fusion is a surgical procedure to fuse two or more vertebrae to restrict their movement. The procedure is recommended to eliminate the pain caused by incorrect movement of vertebrae. Posted via Industry Today. Follow us on Twitter @IndustryToday
November 21, 2017

Electromagnetic Therapy Device Market: Global Industry Analysis and Opportunity and Forecast 2017 to 2023

Electromagnetic Therapy Device Market 2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023 Posted via Industry Today. Follow us on Twitter @IndustryToday
Show more

Orthofix Blogs

October 07, 2020

Orthofix Launches O-GENESIS Graft Delivery System and New Hydrated, Ready-to-Use AlloQuent Structural Allograft Q-PACK

Orthofix Launches O-GENESIS Graft Delivery System and New Hydrated, Ready-to-Use AlloQuent Structural Allograft Q-PACK Content Import Wed, 10/07/2020 - 07:00 Orthofix Launches O-GENESIS Graft Delivery System and New Hydrated, Ready-to-Use AlloQuent Structural Allograft Q-PACK …
October 06, 2020

Orthofix Announces Presentation of Clinical and Scientific Abstracts During the North American Spine Society Annual Meeting

Orthofix Announces Presentation of Clinical and Scientific Abstracts During the North American Spine Society Annual Meeting Content Import Tue, 10/06/2020 - 07:01 Orthofix Announces Presentation of Clinical and Scientific Abstracts During the North American Spine Society Annual Meeting …
October 01, 2020

Orthofix FIREBIRD SI Fusion System Receives Additional FDA Clearance for Nanotechnology

Orthofix FIREBIRD SI Fusion System Receives Additional FDA Clearance for Nanotechnology Content Import Thu, 10/01/2020 - 07:01 Orthofix FIREBIRD SI Fusion System Receives Additional FDA Clearance for Nanotechnology 10/01/20 This release is a backfill from a Ne…
September 22, 2020

Orthofix and Neo Medical Announce Partnership to Develop and Market Single-Use Spinal Solutions Focused on Improving Patient Outcomes

Orthofix and Neo Medical Announce Partnership to Develop and Market Single-Use Spinal Solutions Focused on Improving Patient Outcomes Content Import Tue, 09/22/2020 - 07:00 Orthofix and Neo Medical Announce Partnership to Develop and Market Single-Use Spinal Solutions Focused on Improving …

 Orthofix Frequently Asked Questions

  • When was Orthofix founded?

    Orthofix was founded in 1980.

  • Who are Orthofix key executives?

    Orthofix's key executives are Ronald Matricaria, Maria Sainz and James Hinrichs.

  • How many employees does Orthofix have?

    Orthofix has 1,055 employees.

  • What is Orthofix revenue?

    Latest Orthofix annual revenue is $460 m.

  • What is Orthofix revenue per employee?

    Latest Orthofix revenue per employee is $436 k.

  • Who are Orthofix competitors?

    Competitors of Orthofix include Mammotome, Zimmer Biomet and NuVasive.

  • Where is Orthofix headquarters?

    Orthofix headquarters is located at 9 Via delle Nazioni, Z.a.i..

  • Where are Orthofix offices?

    Orthofix has offices in Z.a.i., Sona, Lewisville, Sunnyvale and in 7 other locations.

  • How many offices does Orthofix have?

    Orthofix has 11 offices.